News
GVN Statement on Monkeypox Outbreaks
May 20, 2022 Unusual outbreaks of monkeypox have recently been reported in the US, the UK, Spain, Portugal, and other European countries. The chain of transmission is currently unknown, but it is clear that it involves human to human transmission. Although the virus has been known in the past to rarely cause such human-to-human transmission,…
Read MoreResurgent Outbreaks of Measles
Resurgent Outbreaks of Measles May 18, 2022 Introduction Two years of the COVID-19 pandemic has brought another health crisis to children. The number of measles cases reported worldwide (more than 17,300 cases) has increased by 79 percent in the first two months of 2022 compared to the same time last year (1). Countries with the…
Read MoreImpact of the Omicron variants on the Ongoing Pandemic
Impact of the Omicron variants on the Ongoing Pandemic May 10, 2022 Introduction The emergence of the Omicron variant in November 2021 has led to a rapid surge of COVID-19 cases worldwide. Since then, Omicron has kept evolving into several different sublineages. Furthermore, recombinant Omicron variants have been detected in patients by coinfection with the…
Read MoreGlobal Expansion of Acute Hepatitis Outbreaks in Healthy Children
Global Expansion of Acute Hepatitis Outbreaks in Healthy Children May 5, 2022 Introduction A recent rise in acute hepatitis among children is expanding globally. The UK first reported an unexpected, significant increase in cases of severe acute hepatitis of unknown origin in previously healthy children. According to the WHO (1), as of 21 April 2022,…
Read MoreGlobal Virus Network (GVN) Announces Seven Distinguished International Appointments to Board of Directors
World Leaders In Academia, Business, Government, Healthcare, Philanthropy & Science Commit Their Expertise To Advancing The Development & Expansion Of The GVN Baltimore, MD, USA (May 3, 2022) â The Global Virus Network (GVN), a coalition of the worldâs leading medical virology research centers working together to prevent illness and death from viral disease, today announced…
Read MoreSpecialized Pro-Resolving Mediators (SPMs) as Potential Covid-19 Therapeutic
April 21, 2022 Introduction Our last Perspective described how the timing of the type 1 interferon (IFN) response is a critical early point in determining whether infection with SARS-CoV2 will lead to severe disease or not. IFN activity later in infection, when disease has already developed, is apparently ineffective, and is instead detrimental. Indeed, an…
Read MoreJapanese Encephalitis Virus: Ongoing Public Health Threat
April 7, 2022 Introduction Japanese encephalitis virus (JEV) is the leading cause of vaccine-preventable encephalitis. JEV is a flavivirus (genus Flavivirus, family Flaviviridae) and shares a close genetic and antigenic relationship with West Nile virus, St. Louis encephalitis virus, and Murray Valley encephalitis virus (1). Most people infected with JE do not have symptoms or…
Read MoreGLOBAL VIRUS NETWORK AND ABBOTT LAUNCH PANDEMIC DEFENSE POSTDOCTORAL FELLOWSHIP PROGRAM
The partnership is training the next generation of virologists to combat future pandemic threats, with a focus on pathogen discovery in developing nations Baltimore, Maryland, USA, April 6, 2022 – The Global Virus Network (âGVNâ), the worldâs leading coalition of virologists combatting current and emerging pandemic viral threats, and Abbott, the global healthcare company, announce…
Read MoreâLIVEâ POLIO VACCINE FIRES UP IMMUNE SYSTEM PROVIDING PROTECTION FROM SARS-CoV-2 INFECTION
Global Virus Network (GVN) studies suggest that the oral polio vaccine can protect people in developing nations that do not yet have access to COVID vaccines Baltimore, Maryland, USA, March 31, 2022: Two new studies from the Global Virus Network (GVN) in partnership with the Petroleum Industry Health Organization of Iran provide evidence that getting…
Read MoreImpact of Interferon on Disease Severity of Covid-19
Impact of Interferon on Disease Severity of Covid-19 March 28, 2022 Introduction Types 1 and 3 interferon (IFN) expression and activity have been shown to play a significant role in determining the disease severity of SARS-CoV-2 infection. It is becoming clear that the timing of IFN expression is critical in the efficacy of the early…
Read More